| Adverse drug reactions: definitions, diagnosis, and management IR Edwards, JK Aronson The lancet 356 (9237), 1255-1259, 2000 | 4080 | 2000 |
| A new taxonomy for describing and defining adherence to medications B Vrijens, S De Geest, DA Hughes, K Przemyslaw, J Demonceau, ... British journal of clinical pharmacology 73 (5), 691-705, 2012 | 2343 | 2012 |
| The SCARE statement: consensus-based surgical case report guidelines RA Agha, AJ Fowler, A Saeta, I Barai, S Rajmohan, DP Orgill, R Afifi, ... International journal of surgery 34, 180-186, 2016 | 1933 | 2016 |
| CARE guidelines for case reports: explanation and elaboration document DS Riley, MS Barber, GS Kienle, JK Aronson, T von Schoen-Angerer, ... Journal of clinical epidemiology 89, 218-235, 2017 | 1668 | 2017 |
| STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery R Agha, A Abdall-Razak, E Crossley, N Dowlut, C Iosifidis, G Mathew, ... International journal of surgery 72, 156-165, 2019 | 1452 | 2019 |
| Meyler's Side Effects of Drugs 15E: The International Encyclopedia of Adverse Drug Reactions and Interactions JK Aronson Newnes, 2014 | 995 | 2014 |
| Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, ... Journal of Psychopharmacology 30 (6), 495-553, 2016 | 902 | 2016 |
| The STROCSS statement: strengthening the reporting of cohort studies in surgery RA Agha, MR Borrelli, M Vella-Baldacchino, R Thavayogan, DP Orgill, ... International Journal of Surgery 46, 198-202, 2017 | 807 | 2017 |
| Medication errors: definitions and classification JK Aronson British journal of clinical pharmacology 67 (6), 599-604, 2009 | 667 | 2009 |
| Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature IJ Onakpoya, CJ Heneghan, JK Aronson BMC medicine 14, 1-11, 2016 | 639 | 2016 |
| Evaluation and stages of surgical innovations JS Barkun, JK Aronson, LS Feldman, GJ Maddern, SM Strasberg The Lancet 374 (9695), 1089-1096, 2009 | 625 | 2009 |
| Compliance, concordance, adherence JK Aronson British journal of clinical pharmacology 63 (4), 383, 2007 | 508 | 2007 |
| Medication errors: what they are, how they happen, and how to avoid them JK Aronson QJM: An International Journal of Medicine 102 (8), 513-521, 2009 | 484 | 2009 |
| Chloroquine and hydroxychloroquine in covid-19 RE Ferner, JK Aronson Bmj 369, 2020 | 479 | 2020 |
| Clarification of terminology in medication errors: definitions and classification RE Ferner, JK Aronson Drug safety 29, 1011-1022, 2006 | 462 | 2006 |
| Biomarkers—a general review JK Aronson, RE Ferner Current protocols in pharmacology 76 (1), 9.23. 1-9.23. 17, 2017 | 448 | 2017 |
| Oxford textbook of clinical pharmacology and drug therapy DG Grahame-Smith Oxford University Press, 2002 | 441 | 2002 |
| Clarification of terminology in drug safety JK Aronson, RE Ferner Drug safety 28, 851-870, 2005 | 402 | 2005 |
| Biomarkers and surrogate endpoints JK Aronson British journal of clinical pharmacology 59 (5), 491, 2005 | 392 | 2005 |
| Joining the DoTS: new approach to classifying adverse drug reactions JK Aronson, RE Ferner Bmj 327 (7425), 1222-1225, 2003 | 391 | 2003 |
